These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26622626)

  • 1. Expression levels of B7-H3 and TLT-2 in human oral squamous cell carcinoma.
    Zhang SS; Tang J; Yu SY; Ma LI; Wang F; Xie SL; Jin L; Yang HY
    Oncol Lett; 2015 Aug; 10(2):1063-1068. PubMed ID: 26622626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses.
    Hashiguchi M; Kobori H; Ritprajak P; Kamimura Y; Kozono H; Azuma M
    Proc Natl Acad Sci U S A; 2008 Jul; 105(30):10495-500. PubMed ID: 18650384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunoregulatory protein B7-H3 promotes aerobic glycolysis in oral squamous carcinoma via PI3K/Akt/mTOR pathway.
    Li Z; Liu J; Que L; Tang X
    J Cancer; 2019; 10(23):5770-5784. PubMed ID: 31737114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of immune checkpoints in oral squamous cell carcinoma.
    Sieviläinen M; Almahmoudi R; Al-Samadi A; Salo T; Pirinen M; Almangush A
    Oral Dis; 2019 Sep; 25(6):1435-1445. PubMed ID: 30315712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7-H3 in tumors: friend or foe for tumor immunity?
    Li G; Quan Y; Che F; Wang L
    Cancer Chemother Pharmacol; 2018 Feb; 81(2):245-253. PubMed ID: 29299639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Expression Patterns and Associated Clinical Parameters of Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 and Transmembrane and Immunoglobulin Domain Containing 2 in Oral Squamous Cell Carcinoma.
    Xiao Y; Li H; Yang LL; Mao L; Wu CC; Zhang WF; Sun ZJ
    Dis Markers; 2019; 2019():5421985. PubMed ID: 31089395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoprotein B7-H3 overexpression and aberrant glycosylation in oral cancer and immune response.
    Chen JT; Chen CH; Ku KL; Hsiao M; Chiang CP; Hsu TL; Chen MH; Wong CH
    Proc Natl Acad Sci U S A; 2015 Oct; 112(42):13057-62. PubMed ID: 26438868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H3 and H3.3 histone mRNA amounts and ratio in oral squamous cell carcinoma and leukoplakia.
    Piscopo M; Campisi G; Colella G; Bilancione M; Caccamo S; Di Liberto C; Tartaro GP; Giovannelli L; Pulcrano G; Fucci L
    Oral Dis; 2006 Mar; 12(2):130-6. PubMed ID: 16476033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research Progress on Co-stimulating Molecule B7-H3 in Hematological Malignancies].
    Zhang W; Wang J; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1758-62. PubMed ID: 26708906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic B7-H3 therapy induces tumor-specific immune response in human oral squamous cell cancer: an in vitro study.
    Yang HY; Chu M; Zheng LW; Zwahlen RA; Luo J; Zou DH; Sun ST
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Nov; 106(5):721-8. PubMed ID: 18929994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and Subcellular Distribution of Costimulatory Molecules B7-H1,B7-H3 and B7-H4 in Human Hematologic Malignancy Cell Lines].
    Zhang W; Wang J; Wang YF; Zhu MX; Wan WL; Li HS; Wu FF; Yan XX; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1539-1546. PubMed ID: 27784389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma.
    Wang L; Cao NN; Wang S; Man HW; Li PF; Shan BE
    Tumour Biol; 2016 Mar; 37(3):2961-71. PubMed ID: 26411671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-H3 and B7-H4 expression in non-small-cell lung cancer.
    Sun Y; Wang Y; Zhao J; Gu M; Giscombe R; Lefvert AK; Wang X
    Lung Cancer; 2006 Aug; 53(2):143-51. PubMed ID: 16782226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7-H3 and CD133 expression in non-small cell lung cancer and correlation with clinicopathologic factors and prognosis.
    Xu YH; Zhang GB; Wang JM; Hu HC
    Saudi Med J; 2010 Sep; 31(9):980-6. PubMed ID: 20844808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells.
    Arigami T; Uenosono Y; Hirata M; Yanagita S; Ishigami S; Natsugoe S
    Cancer Sci; 2011 May; 102(5):1019-24. PubMed ID: 21251161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis.
    Katayama A; Takahara M; Kishibe K; Nagato T; Kunibe I; Katada A; Hayashi T; Harabuchi Y
    Int J Oncol; 2011 May; 38(5):1219-26. PubMed ID: 21344157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Squamous Carcinoma Cells Express B7-H1 and B7-DC Receptors in Vivo.
    Groeger S; Howaldt HP; Raifer H; Gattenloehner S; Chakraborty T; Meyle J
    Pathol Oncol Res; 2017 Jan; 23(1):99-110. PubMed ID: 27498988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of the B7/CD28 family member B7-H3 in bladder cancer.
    Wu D; Zhang Z; Pan H; Fan Y; Qu P; Zhou J
    Oncol Lett; 2015 Mar; 9(3):1420-1424. PubMed ID: 25663925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis.
    Wu CP; Jiang JT; Tan M; Zhu YB; Ji M; Xu KF; Zhao JM; Zhang GB; Zhang XG
    World J Gastroenterol; 2006 Jan; 12(3):457-9. PubMed ID: 16489649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.